CION Ameerpet
Childhood Kidney Cancer — Parent’s Guide
Bilateral Wilms tumour — when both kidneys are affected
Medically reviewed by Dr. C. Raghavendra Reddy, DM (Medical Oncology, Gold Medal) · Last reviewed June 2026
If your child has received a diagnosis of bilateral Wilms tumour — also called bilateral nephroblastoma, or Wilms tumour in both kidneys — this page is written for you. We explain what it is, why it is different from the more common single-kidney form, how doctors diagnose and stage it, and what modern treatment aims to achieve. You deserve clear answers, not just medical shorthand.
- Tumor board for every child — medical, surgical, and radiation oncologists review your child’s case together before any treatment is decided
- 45-minute consultations — long enough to go through every report, every question, and every concern without feeling rushed
- Free first consultation — bring any reports or scans you already have; our team will review them at no charge
- Transparent costs — written treatment plan and cost estimate before anything begins, no surprises
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Understanding the diagnosis
What is bilateral Wilms tumour?
Wilms tumour — also known as nephroblastoma — is a cancer that arises in the kidneys and is almost exclusively a disease of young children. Most cases are diagnosed in children between the ages of three and four, though it can be found in infants and in children up to the age of about six. In the majority of cases, only one kidney is involved. When both kidneys develop tumours at the same time — a condition called bilateral Wilms tumour or bilateral nephroblastoma — the situation requires a different approach from the outset.
The word “bilateral” simply means “both sides.” Bilateral Wilms tumour means tumours are present in both the left and the right kidney simultaneously. This is called synchronous bilateral disease (as opposed to a situation where a second kidney tumour appears years later, which would be called metachronous). In bilateral disease, the oncology team faces a dual challenge: removing the cancer from both kidneys while preserving as much healthy kidney tissue as possible, so that the child can continue to produce urine and live without needing dialysis or a transplant.
Wilms tumour begins in cells called nephrogenic rests — small clusters of primitive kidney cells that failed to mature normally during the baby’s development in the womb. These cells should have disappeared before birth, but in some children they persist and, over the first few years of life, can begin to grow into tumours. In bilateral disease, these immature rests are present in both kidneys. This is more likely in children with certain genetic predispositions, though many children with bilateral disease have no prior family history of kidney problems and no identified syndrome.
Bilateral Wilms tumour is not caused by anything the parents did before or during pregnancy. The changes that lead to bilateral disease happen at the level of kidney cell development — events that are outside any family’s control.
What makes bilateral Wilms tumour different
How bilateral nephroblastoma differs from one-kidney disease
Single-kidney Wilms tumour and bilateral Wilms tumour are related conditions, but they are managed very differently. Understanding the key differences helps parents make sense of the treatment decisions their child’s team proposes.
Kidney preservation
Saving both kidneys is the primary goal
In a child with a single-kidney tumour, removing the affected kidney entirely (nephrectomy) is usually safe because the other kidney takes over. In bilateral disease, both kidneys contain tumour. Removing both is possible but would leave the child without any kidney function, requiring life-long dialysis and eventual transplant. The treatment strategy in bilateral disease is designed from the start to remove as little healthy kidney as possible.
- Pre-surgical chemotherapy is always given first to shrink tumours
- Nephron-sparing surgery (partial nephrectomy) is the aim wherever feasible
- Kidney function is monitored closely throughout and after treatment
Treatment sequence
Chemotherapy comes before surgery
In bilateral Wilms tumour, the standard approach worldwide is to start with chemotherapy before any surgery is attempted. This is called neoadjuvant or pre-operative chemotherapy. The goal is to shrink the tumours in both kidneys, making kidney-sparing surgery more achievable. After a defined period of chemotherapy, repeat imaging assesses how much the tumours have responded. Surgery is then performed when the best possible kidney-preserving outcome is likely.
- Surgery upfront carries a higher risk of removing too much kidney tissue
- Response to chemotherapy guides the timing and approach of surgery
- Post-operative chemotherapy continues after surgery based on pathology findings
Genetic assessment
Genetic testing is strongly recommended
Because bilateral Wilms tumour is more likely to occur in children with an underlying genetic predisposition, the oncology team will typically recommend genetic counselling and testing early in the diagnostic process. Identifying a predisposing syndrome changes the long-term surveillance plan for the child and may have implications for other family members. This is an important conversation to have with the team, even if there is no family history of kidney problems.
- Syndromes linked to bilateral disease include WAGR, Denys-Drash, and Beckwith-Wiedemann
- Genetic findings do not change the immediate treatment approach but affect long-term care
- Genetic counsellors explain findings in plain language and address family implications
Long-term kidney health
Lifelong kidney monitoring after treatment
Even after successful treatment of bilateral Wilms tumour, the child will have less total kidney tissue than if both kidneys were completely normal. The remaining tissue is carefully monitored over the years to ensure it stays healthy. Children treated for bilateral disease need long-term follow-up with a nephrologist (kidney specialist) alongside the oncology team, to catch any changes in kidney function early and to take steps to protect the kidneys across childhood and into adult life.
- Regular blood pressure checks are part of standard follow-up
- Urine tests and kidney function blood tests are repeated at defined intervals
- Lifestyle guidance on protecting kidney health is given as the child grows
These differences make the involvement of a specialist paediatric oncology centre with multidisciplinary expertise essential for children with bilateral disease. — Explore the pediatric cancer hub
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your child deserves a second opinion from a specialist team
In bilateral Wilms tumour, the sequence of treatment decisions matters enormously. A multidisciplinary review before anything begins gives your child the best chance of preserving kidney function.
The diagnostic and treatment journey
How bilateral Wilms tumour is diagnosed and treated, step by step
Understanding what lies ahead can make the journey less frightening. Below is an overview of the steps most children with bilateral nephroblastoma go through — from initial suspicion to the end of active treatment.
Initial imaging: ultrasound and CT or MRI
When a child presents with an abdominal lump — or when a doctor feels something unusual during an examination — the first investigation is an ultrasound. This is painless and does not involve any radiation. The ultrasound can show that one or both kidneys contain a mass. A CT scan or MRI of the abdomen and chest is then done to get a precise picture: the size of each tumour, its exact location within each kidney, whether it has grown into the blood vessels that drain the kidneys (vascular involvement), whether lymph nodes near the kidneys are affected, and whether there are any deposits in the lungs or liver. These images guide every decision that follows.
Blood tests, urine tests, and kidney function assessment
Blood tests measure how well the kidneys are currently working (creatinine, electrolytes, kidney function panel). A urine test checks for blood in the urine. Blood pressure is measured, because Wilms tumour can sometimes cause high blood pressure. These baseline measurements are important because they tell the team how much functional kidney capacity the child has before treatment begins, which guides how aggressively the surgical team can remove tissue later.
Multidisciplinary tumour board review before any treatment
At CION, every child with a diagnosis or strong suspicion of bilateral Wilms tumour is reviewed at a multidisciplinary tumour board before any treatment is started. This brings together the medical oncologist, paediatric surgical oncologist, radiation oncologist, radiologist who reviewed the scans, and the pathology team. The board confirms the most likely diagnosis, decides whether any additional investigations are needed, and agrees the initial treatment plan. This takes time — but it is time well spent. Decisions made at this stage affect the entire course of treatment.
Pre-surgical chemotherapy to shrink tumours in both kidneys
In bilateral Wilms tumour, chemotherapy is given before surgery. This is the standard approach recommended by both the Children’s Oncology Group (COG) in North America and the International Society of Paediatric Oncology (SIOP) in Europe. Chemotherapy is given through a vein (intravenously) over a series of cycles spanning several weeks. The goal is to reduce the size of the tumours in both kidneys so that surgeons have a better chance of removing only the tumour-bearing tissue, leaving as much healthy kidney as possible. The team will explain what medications will be used, what side effects to expect, and how to support your child at home during treatment.
Response assessment: imaging after chemotherapy
After the pre-surgical chemotherapy course is complete, imaging is repeated — usually CT or MRI — to measure how much the tumours have shrunk. The surgical team reviews these images carefully alongside the original scans. They assess the new tumour size, whether the tumour boundaries are now clearer, and how much healthy kidney tissue remains around each tumour. This assessment determines whether kidney-sparing surgery is now feasible and, if so, plans the surgical approach for each kidney individually.
Kidney-sparing surgery (nephron-sparing surgery)
Surgery for bilateral Wilms tumour aims to remove the tumour from each kidney while leaving as much functioning kidney tissue behind as possible. This is called nephron-sparing surgery, partial nephrectomy, or tumour enucleation, depending on the extent of what needs to be removed. In some children, the response to chemotherapy is excellent and surgeons can remove only the tumour-containing segments. In others, the tumour involves such a large portion of one kidney that more tissue must be removed from that side, while the other kidney can be preserved more fully. The exact surgical plan is tailored to each child’s specific anatomy after chemotherapy response. The tissue removed is sent to the pathology laboratory to confirm the diagnosis and assess the tumour’s histological features, which guide further treatment.
Post-operative chemotherapy and possible radiation therapy
After surgery, the pathology findings from the removed tissue determine what further treatment is needed. Chemotherapy continues in the post-operative phase. The specific duration and agents used depend on the pathological findings — particularly the histological type of the tumour (favourable histology versus anaplastic histology) and whether the surgical margins were clear. Radiation therapy to the flank area (where the kidneys are) may be recommended in certain circumstances. Your child’s oncology team will explain what the pathology report showed and what it means for the next steps.
Long-term follow-up to protect kidney health
After active treatment ends, children treated for bilateral Wilms tumour enter a period of structured follow-up. This includes regular imaging to check for any sign of recurrence, blood tests and urine tests to monitor kidney function, and blood pressure checks. As the child grows, kidney function and blood pressure may need ongoing management — this is where a paediatric nephrologist (kidney specialist) becomes an important part of the long-term care team. The oncology team will set up a clear follow-up schedule and explain what symptoms to watch for in between appointments.
Ready to speak with our paediatric oncology team?
Free consultation for all new patients — bring your reports and we will review them together.
You don’t have to face this alone
We walk this journey with you and your family
Every consultation is 45 minutes. Every child’s case goes to the tumour board. Every treatment plan is explained in full before anything begins. Decisions for healing, not billing.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Your questions about bilateral Wilms tumour — answered
What is bilateral Wilms tumour and how is it different from a single-kidney Wilms tumour?
Bilateral Wilms tumour — also called bilateral nephroblastoma — means that Wilms tumour (a kidney cancer that develops in children) is present in both kidneys at the same time. In most children diagnosed with Wilms tumour, only one kidney is affected (this is called unilateral disease). When both kidneys are involved, the clinical situation is more complex because the treatment team must plan to remove or destroy cancer cells in both kidneys while preserving as much healthy kidney tissue as possible, so that the child can live without dialysis. Bilateral disease accounts for a minority of all Wilms tumour cases. It is more likely to be found in children who carry certain predisposing genetic conditions, though many children with bilateral disease have no prior family history and no identified genetic syndrome.
How does bilateral Wilms tumour happen? What causes it?
Wilms tumour arises from abnormal kidney cells called nephrogenic rests — clusters of primitive kidney tissue that should have matured normally during foetal development but instead remain in an immature state after birth. In bilateral disease, these abnormal rests are present in both kidneys and can give rise to tumours in both. The reason this happens is partly genetic. Some children with bilateral Wilms tumour carry changes in genes that regulate kidney development, including WT1 and other genes involved in the Wilms tumour pathway. Certain inherited syndromes increase the risk of bilateral disease significantly. Even so, the majority of Wilms tumour cases — including bilateral cases — occur in children with no identifiable genetic syndrome and no family history of the condition. In most cases, the genetic changes happen within the kidney cells themselves during development, not in every cell of the body.
What are the signs that a child might have Wilms tumour in both kidneys?
The signs of bilateral Wilms tumour are the same as those of single-kidney Wilms tumour, because the most common presentation is a swelling or lump in the abdomen. Parents often notice this while bathing or dressing the child, or a doctor may feel it during a routine check. The abdomen may look or feel larger on one or both sides. Other signs that sometimes appear include: blood in the urine (haematuria), which may give the urine a pink or red colour; high blood pressure, which the child cannot feel but which a doctor can measure and which may cause headache or irritability; abdominal pain that the child finds difficult to localise; fever without a clear source; general tiredness and loss of appetite; or nausea. None of these signs by themselves confirm Wilms tumour — they all have other more common causes — but any of them in a young child, especially a lump in the abdomen, warrants prompt medical attention.
How is bilateral Wilms tumour diagnosed?
When a doctor suspects Wilms tumour — usually after feeling an abdominal mass — the first investigation is an ultrasound of the abdomen, which can show a kidney mass and give an initial impression of whether both kidneys are involved. A CT scan or MRI of the abdomen and chest is then done to precisely define the tumours in both kidneys, assess whether tumour cells have entered blood vessels (vascular involvement), check for lymph node involvement, and look for spread to the lungs or other organs. Blood and urine tests are done to assess kidney function and look for haematuria. A chest X-ray or CT checks for lung metastases, which Wilms tumour can sometimes produce. In bilateral disease, the oncology team generally does not perform a needle biopsy of the tumour upfront — imaging is usually sufficient to establish the diagnosis and plan initial treatment. Formal pathological diagnosis comes from the tissue removed during surgery. The team will also discuss genetic testing, because identifying a predisposing syndrome (such as WAGR syndrome, Denys-Drash syndrome, or Beckwith-Wiedemann syndrome) affects how the child is followed up long-term.
What does treatment for bilateral Wilms tumour look like?
Treatment for bilateral Wilms tumour is carefully individualised because saving kidney function while removing cancer is a dual goal. The internationally accepted approach used at most specialist centres involves starting with chemotherapy before any surgery is attempted. This pre-surgical (neoadjuvant) chemotherapy is given to shrink the tumours in both kidneys. After several weeks, imaging is repeated to measure response. The surgical team then assesses whether nephron-sparing surgery — operations designed to remove only the tumour-bearing parts of each kidney while leaving functioning kidney tissue behind — is feasible. The aim is to avoid removing both kidneys entirely (bilateral nephrectomy), which would require the child to be on dialysis and eventually need a kidney transplant. After surgery, the child typically receives further chemotherapy based on the pathology of the removed tumours. Radiation therapy may be added depending on the findings. Throughout treatment, kidney function is monitored carefully. Every step is planned by a multidisciplinary team that includes paediatric oncologists, paediatric urologists or surgical oncologists, radiation oncologists, and nephrologists.
Will my child need to have both kidneys removed?
The goal of treatment in bilateral Wilms tumour is to avoid removing both kidneys wherever possible. Removing both kidneys (bilateral nephrectomy) would mean the child would need dialysis to survive and would eventually need a kidney transplant — a very significant long-term burden for a young child. That is why the standard treatment approach at specialist centres starts with chemotherapy first, to shrink the tumours in both kidneys. Once the tumours have responded, surgeons assess whether nephron-sparing procedures — partial nephrectomy, tumour enucleation, or similar kidney-preserving operations — can remove the remaining cancer while leaving enough healthy kidney tissue to maintain function. The feasibility of kidney-sparing surgery depends on the size and location of the tumours after chemotherapy and the anatomy of each kidney’s blood vessels. In some cases, despite optimal chemotherapy, bilateral nephrectomy cannot be avoided. Your child’s surgical and oncology team will explain clearly what is possible for your child’s specific situation.
Pediatric Cancer A–Z
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.